Why should pharma invest in digital products for those living with rare diseases?
pharmaphorum
NOVEMBER 23, 2022
Consultations and clinical trials are often few and far between. This could considerably increase the quality of consultations by allowing patients to consider and communicate with their practitioners, not just about the recent weeks, but about the past months or years.
111 
Let's personalize your content